Randomised clinical trial: Pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 878-887

  Olesen, S S ^a   Graversen, C ^a   Olesen, A E ^a   Frokjaer J B ^a   Wilder Smith, O ^b,c   Van Goor, H ^b   Valeriani, M ^c,d   Drewes, A M ^a,c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AALBORG UNIVERSITY   (Denmark)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; ANTINOCICEPTION; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN NERVE CELL; CELL ACTIVITY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; EVENING DOSAGE; EVOKED CORTICAL RESPONSE; FEMALE; GASTROINTESTINAL PAIN; HUMAN; HYPERALGESIA; IMAGE ANALYSIS; MALE; MORNING DOSAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN THRESHOLD; PARALLEL DESIGN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOID; TREATMENT DURATION; TREATMENT RESPONSE; VISCERAL PAIN; VISUAL ANALOG SCALE;

ADULT; AGED; ANALGESICS; BRAIN MAPPING; CEREBRAL CORTEX; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; PANCREATITIS, CHRONIC; TREATMENT OUTCOME; VISCERAL PAIN;

EID: 80053189714     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04802.x     Document Type: Article

References (45)

1. Lieb JG, Forsmark CE,. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther 2009; 29: 706-19.
2. Dimcevski G, Staahl C, Andersen SD, et al. Assessment of experimental pain from skin, muscle, and esophagus in patients with chronic pancreatitis. Pancreas 2007; 35: 22-9. (Pubitemid 46956197)
3. Dimcevski G, Sami SA, Funch-Jensen P, et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 2007; 132: 1546-56. (Pubitemid 46627573)
4. Buscher HC, Wilder-Smith OH, van GH,. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain 2006; 10: 363-70.
5. Olesen SS, Brock C, Krarup AL, et al. Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2010; 8: 724-30.
6. Olesen SS, Frokjaer JB, Lelic D, Valeriani M, Drewes AM,. Pain-associated adaptive cortical reorganisation in chronic pancreatitis. Pancreatology 2011; 10: 742-51.
7. Finnerup NB, Sindrup SH, Jensen TS,. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-81.
8. Olesen SS, Bouwense SA, van Goor H, Wilder-Smith OH, Drewes AM,. Pregabalin reduces pain in patients with chronic pancreatitis, in a randomized, controlled trial. Gastroenterology 2011 [Epub ahead of print].
9. Diop L, Raymond F, Fargeau H, Petoux F, Chovet M, Doherty AM,. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther 2002; 302: 1013-22. (Pubitemid 34920221)
10. Ravnefjord A, Brusberg M, Larsson H, Lindstrom E, Martinez V,. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 2008; 155: 407-16.
11. Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca(2 +) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42: 229-36. (Pubitemid 34137026)
12. Dooley DJ, Donovan CM, Pugsley TA,. Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000; 295: 1086-93.
13. Fehrenbacher JC, Taylor CP, Vasko MR,. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003; 105: 133-41. (Pubitemid 37162482)
14. Million M, Wang L, Adelson DW, Roman F, Diop L, Tache Y,. Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut 2007; 56: 1482-4. (Pubitemid 47517859)
15. Mayer EA, Aziz Q, Coen S, et al. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil 2009; 21: 579-96.
16. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK,. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463-84. (Pubitemid 40836040)
17. Bromm B, Scharein E, Vahle-Hinz C,. Cortex areas involved in the processing of normal and altered pain. Prog Brain Res 2000; 129: 289-302. (Pubitemid 35461201)
18. Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM,. Assessing analgesic actions of opioids by experimental pain models in healthy volunteers-an updated review. Br J Clin Pharmacol 2009; 68: 149-68.
19. Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM,. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol 2009; 68: 322-41.
20. Michel CM, Murray MM, Lantz G, Gonzalez S, Spinelli L, Grave de PR,. EEG source imaging. Clin Neurophysiol 2004; 115: 2195-222. (Pubitemid 39200787)
21. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP,. The different courses of early-and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-7. (Pubitemid 24328288)
22. Brock C, Nissen TD, Gravesen FH, et al. Multimodal sensory testing of the rectum and rectosigmoid: development and reproducibility of a new method. Neurogastroenterol Motil 2008; 20: 908-18. (Pubitemid 352019716)
23. Brock C, Andresen T, Frokjaer JB, et al. Central pain mechanisms following combined acid and capsaicin perfusion of the human oesophagus. Eur J Pain 2010; 14: 273-81.
24. Rossel P, Arendt-Nielsen L, Niddam D, Chen AC, Drewes AM,. Short latency cerebral response evoked by painful electrical stimulation applied to the human sigmoid colon and to the convergent referred somatic pain area. Exp Brain Res 2003; 151: 115-22. (Pubitemid 36819161)
25. Gallen CC, Sobel DF, Lewine JD, et al. Neuromagnetic mapping of brain function. Radiology 1993; 187: 863-7. (Pubitemid 23155729)
26. Valeriani M, Le PD, Tonali P,. Characterizing somatosensory evoked potential sources with dipole models: advantages and limitations. Muscle Nerve 2001; 24: 325-39. (Pubitemid 32172707)
27. Soffer EE, Kongara K, Achkar JP, Gannon J,. Colonic motor function in humans is not affected by gender. Dig Dis Sci 2000; 45: 1281-4. (Pubitemid 30636502)
28. Sloots CE, Felt-Bersma RJ, Cuesta MA, Meuwissen SG,. Rectal visceral sensitivity in healthy volunteers: influences of gender, age and methods. Neurogastroenterol Motil 2000; 12: 361-8. (Pubitemid 30458590)
29. Cervero F,. Visceral versus somatic pain: similarities and differences. Dig Dis 2009; 27 (Suppl 1): 3-10.
30. Sherman JJ, LeResche L,. Does experimental pain response vary across the menstrual cycle? A methodological review. Am J Physiol Regul Integr Comp Physiol 2006; 291: R245-56. (Pubitemid 44035629)
31. Staahl C, Dimcevski G, Andersen SD, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 2007; 42: 383-90.
32. Iannetti GD, Zambreanu L, Wise RG, et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci USA 2005; 102: 18195-200. (Pubitemid 41798524)
33. Drewes AM, Gregersen H, Arendt-Nielsen L,. Experimental pain in gastroenterology: a reappraisal of human studies. Scand J Gastroenterol 2003; 38: 1115-30. (Pubitemid 37518595)
34. Olesen AE, Staahl C, Arendt-Nielsen L, Drewes AM,. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study. Br J Clin Pharmacol 2010; 70: 189-200.
35. Wang Y, Gotman J,. The influence of electrode location errors on EEG dipole source localization with a realistic head model. Clin Neurophysiol 2001; 112: 1777-80. (Pubitemid 32763261)
36. Houghton LA, Fell C, Whorwell PJ, Jones I, Sudworth DP, Gale JD,. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007; 56: 1218-25. (Pubitemid 47300421)
37. Chua YC, Ng KS, Jafa J, et al. Pregabalin prevents development of esophageal hypersensitivity to esophageal acid infusion in healthy volunteers. Gastroenterology 2011; 138 (Supplement 1): 134.
38. Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q,. A cortical evoked potential study of afferents mediating human esophageal sensation. Am J Physiol Gastrointest Liver Physiol 2000; 279: G139-47. (Pubitemid 30612692)
39. Dolgin E,. Animalgesic effects. Nat Med 2010; 16: 1237-40.
40. Arendt-Nielsen L, Frokjaer JB, Staahl C, et al. Effects of gabapentin on experimental somatic pain and temporal summation. Reg Anesth Pain Med 2007; 32: 382-8. (Pubitemid 47600012)
41. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN,. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271: 5768-76. (Pubitemid 26083915)
42. Suzuki R, Rahman W, Rygh LJ, Webber M, Hunt SP, Dickenson AH,. Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain 2005; 117: 292-303. (Pubitemid 41383525)
43. Gebhart GF,. Descending modulation of pain. Neurosci Biobehav Rev 2004; 27: 729-37. (Pubitemid 38199605)
44. Stanfa LC, Singh L, Williams RG, Dickenson AH,. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 1997; 8: 587-90. (Pubitemid 27128198)
45. Drewes AM, Dimcevski G, Sami SA, et al. The "human visceral homunculus" to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon. Exp Brain Res 2006; 174: 443-52. (Pubitemid 44451038)